Glanbia has raised its full-year revenue and profit forecasts after a “strong” first half across the group’s divisions, including Performance Nutrition.
The Ireland-based company, which owns brands such as Optimum Nutrition and Isopure, now expects adjusted earnings per share (EPS) to grow 17-20% on a constant-currency basis in 2026.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It had previously guided to the upper end of a 7-11% range.
CEO Hugh McGuire said today (6 August) that adjusted EPS growth “will be driven by category and end-use consumer market demand and a strong operating performance across all three segments”.
Glanbia raised its outlook for like-for-like revenue growth in its Performance Nutrition unit to 12-14%, from the upper end of its prior 5-7% range.
In Health and Nutrition, it upped growth expectations to 8-10%, from the high end of 4-6% previously. Its forecast for dairy nutrition EBITDA was lifted to $170m-$180m, from $160m-$170m.
For the six months to 4 July, Glanbia’s group revenue rose 7% on a constant-currency basis to $2.1bn, while reported sales were up 7.9% at $2.08bn.
Operating profit increased 52.4% to $190.1m. Profit after tax climbed 54.7% to $153.8m.
Performance Nutrition revenue increased 6.7% to $917.2m, driven by like-for-like growth of 16.9%, with volumes up 9.3% and pricing up 7.6%.
EBITDA in the division rose 7.4% to $115.2m.
Optimum Nutrition, which accounted for 79% of Performance Nutrition sales, posted like-for-like revenue growth of 25.2%.
Glanbia said the brand benefited from category growth, increased distribution and innovation.
In the US, Optimum Nutrition delivered measured consumption growth of 23.5% in the 13 weeks to 4 July.
McGuire said: “We delivered volume and like-for-like revenue growth across all three segments, reflecting disciplined execution as we continue to navigate whey cost inflation within Performance Nutrition.”
Elsewhere, Health & Nutrition and Dairy Nutrition also recorded growth in the half, supported by demand in end-use markets and protein solutions.
